A panel of sputum-based genomic marker for early detection of lung cancer

Cancer Prevention Research

Volumn 3, Issue 12, 2010, Pages 1571-1578

  Jiang, Feng ^a   Todd, Nevins W ^a   Li, Ruiyun ^a   Zhang, Howard ^a   Fang, HongBin ^a   Stass, Sanford A ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOLOGY; ENO1 GENE; FEMALE; FHIT GENE; GENE; HUMAN; HYAL2 GENE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROCHIP ANALYSIS; PRIORITY JOURNAL; SKP2 GENE; SPUTUM ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 78650332564     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0128     Document Type: Article

References (26)

1. Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 2010;102:464-74.
2. Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002;1:49-52.
3. Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR, Carter D, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984;130:549-54.
4. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-44.
5. Varella-Garcia M, Schulte AP, Wolf HJ, Feser WJ, Zeng C, Braudrick S, et al. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res 2010;3:447-53.
6. Qiu Q, Todd NW, Li R, Peng H, Liu Z, Yfantis HG, et al. Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. Cancer 2008;114:275-83.
7. Li R, Liu Z, Fan T, Jiang F. A novel multiple FISH array for the detection of genetic aberrations in cancer. Lab Invest 2006;86:619-27. (Pubitemid 43780443)
8. Jiang F, Yin Z, Caraway NP, Li R, Katz RL. Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 2004;6:623-35. (Pubitemid 39419501)
9. Li R, Todd NW, Qiu Q, Fan T, Zhao RY, Rodgers WH, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007;13:482-7.
10. Colby TV, Wistuba II, Gazdar A. Precursors to pulmonary neoplasia. Adv Anat Pathol 1998;5:205-9.
11. Hammar SP, Brambilla C, Pugatch B. Squamous cell carcinoma. In: Travis WD, Brambilla E, Muller-Hermelink HK, editors. Pathology and Genetics, Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press;2005. p. 26-30.
12. Colby TV, Noguchi M, Henschke C . Adenocarcinoma. In:Travis WD, Brambilla E, Muller-Hermelink HK, editors. Pathology and Genetics, Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press;2005. p. 35-44.
13. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222:773-81. (Pubitemid 34215229)
14. Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010;67:170-6.
15. Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer 2009;66:58-63.
16. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010; Mar 2. [Epub ahead of print]
17. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256-70.
18. Saccomanno G. Diagnostic Pulmonary Cytology. 2nd ed. Chicago (IL): American Society of Clinical Pathologists Press;1986.p.1-211.
19. Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, et al. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene. 2006;18:2628-35.
20. Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, et al. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 2006;12:5746-54.
21. Rácz A, Brass N, Höfer M, Sybrecht GW, Remberger K, Meese EU. Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma. Int J Oncol 2000;17;67-73.
22. Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H, et al. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 2007;16:7901-6.
23. Jiang F, Caraway NP, Li R, Katz RL. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 2005;12:3409-18. (Pubitemid 40756242)
24. Vineis P, Airoldi L, Veglia F, Olgiati L, Pastorelli R, Autrup H, et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005;7486:277. (Pubitemid 40203639)
25. Young RP, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD. Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur Respir J 2008;5:1158-64.
26. Quint LE. Work-up of the solitary pulmonary nodule. Cancer Imaging 2003;3:119-21.